HCV ADVOCATE EBLAST
January 26, 2010

Hello,

The following items have been posted to www.hcvadvocate.org and www.hbvadvocate.org.

Call your Representative Today to Sign Letter In Support of Increased Viral Hepatitis Prevention Funding

Researchers Successfully Grow Hepatitis C Virus in Otherwise Healthy Liver Cells in the Laboratory

HEPATITIS JOURNAL REVIEW:
A Bi-Monthly Publication of the Hepatitis Support Project

January 24 , 2010
Volume 7, Issue 1

Liz Highleyman

In This Issue:

• Relapsers and Nonresponders
  
  
• Pegylated Interferon Maintenance
  
  
• Fibrosis Progression in Nonresponders
  
  
• Sorafenib Inhibits HCV Replication
  
  
• HCV and Sleep Disorders
  
  
• Effect of CD4 Count in HIV/HCV Coinfection

Hepatitis C Treatments in Current Clinical Development — Updated January 24, 2010

Hepatitis B Basic Educator Training Workshop Sacramento, CA Feb 2, 2010

*** HCV ADVOCATE WEEKLY NEWS REVIEW:
A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights
Week Ending: January 23, 2010

Alan Franciscus
Editor-in-Chief

To download pdf version click here
 

This Issue:

• ACT Jail Needle Exchange a Safer Option for All
• Ga. Congressman to Run Again, despite Hepatitis C
• Proven Effective, Needle Exchange Banned in Fla.
• Public Health Warns Barber Shops against Re-Using Razors
• ‘Drug Addict’ Tech Who Infected 36 Pleads Guilty
• Federal Strategy Needed to Prevent Hepatitis B and C
• Telaprevir May Be Viewed More Positively by Clinicians than Boceprevir for Hepatitis C Virus Treatment Following Their Launches in 2011
• A Larger Proportion of Hepatitis C Non-Responder Patients Will Be Treated with Telaprevir than Boceprevir
• New Tests for ‘Silent Killer’ Urged
• £4.5 Million Bill for Junkie Needles
• Can-Fite Launches Liver Cancer Joint Venture in Asia
• Ma Wants to Regulate Tattooing, Piercing
• Proposed Bill Bans Kids under 16 from Getting Tattoos
• Team Finds Potential Path for Hepatitis C Drugs
• Pharmasset Initiates Phase 2a Trial with PSI-7977, a Chirally Pure Isomer of PSI-7851
• Tree Shrew Offers Small-Animal Model of Hepatitis C Virus Infection
• Anadys Pharmaceuticals Provides Progress Update on Phase II Study of ANA598 in Hepatitis C Patients
• Obesity also Ups Liver Cancer Risk
• Dancin' in the Rain
• Charges Coming In Hepatitis C Investigation

*** Be sure to check out the latest event notices at both the HCV and HBV Advocate websites

• HCV Events
• HBV Events

Thanks!
 
Alan Franciscus
Executive Director, Hepatitis C Support Project
Editor-in-Chief, HCV Advocate

**Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@hcvadvocate.org

**Unsubscribe Information: To unsubscribe from this list, simply send an e-mail to: listserv@list.hcvadvocate.org with nothing in the subject line and the following in the message body: unsubscribe emailalert.

Make sure that your email address is all lower case.